I-Mab (IMAB)
USD 0.95
(8.63%)
USD 0.95
(8.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.23 Billion CNY | 37.24% |
| 2022 | -1.96 Billion CNY | 4.92% |
| 2021 | -2.07 Billion CNY | -1431.43% |
| 2020 | 155.57 Million CNY | 110.62% |
| 2019 | -1.46 Billion CNY | -233.98% |
| 2018 | -438.63 Million CNY | -56.12% |
| 2017 | -280.95 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -90.62 Million CNY | 67.88% |
| 2024 Q2 | -109.05 Million CNY | 83.44% |
| 2023 Q3 | -282.12 Million CNY | 16.01% |
| 2023 Q1 | -335.88 Million CNY | 41.53% |
| 2023 FY | -1.23 Billion CNY | 37.24% |
| 2023 Q4 | -282.12 Million CNY | 0.0% |
| 2023 Q2 | -335.88 Million CNY | 0.0% |
| 2022 Q1 | -410.22 Million CNY | 21.46% |
| 2022 Q4 | -574.5 Million CNY | 0.0% |
| 2022 Q3 | -574.5 Million CNY | -40.05% |
| 2022 Q2 | -410.22 Million CNY | 0.0% |
| 2022 FY | -1.96 Billion CNY | 9.53% |
| 2021 Q4 | -522.29 Million CNY | 0.0% |
| 2021 Q1 | -508.85 Million CNY | -143.69% |
| 2021 Q2 | -508.85 Million CNY | 0.0% |
| 2021 Q3 | -522.29 Million CNY | -2.64% |
| 2021 FY | -2.07 Billion CNY | -549.34% |
| 2020 Q4 | 1.16 Billion CNY | 394.47% |
| 2020 Q1 | -306.83 Million CNY | 8.09% |
| 2020 Q2 | -306.83 Million CNY | 0.0% |
| 2020 FY | 155.57 Million CNY | 131.47% |
| 2020 Q3 | -395.56 Million CNY | -28.92% |
| 2019 Q2 | -412.33 Million CNY | 0.0% |
| 2019 FY | -1.46 Billion CNY | -233.98% |
| 2019 Q4 | -333.85 Million CNY | -8.95% |
| 2019 Q3 | -306.44 Million CNY | 25.68% |
| 2019 Q1 | -412.33 Million CNY | -225.84% |
| 2018 Q1 | -100 Million CNY | 0.0% |
| 2018 Q2 | -100 Million CNY | 0.0% |
| 2018 Q3 | -112.09 Million CNY | -12.09% |
| 2018 Q4 | -126.54 Million CNY | -12.89% |
| 2018 FY | -438.63 Million CNY | -56.12% |
| 2017 FY | -280.95 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Absci Corporation | -115.51 Million USD | -970.007% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -444.418% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -338.033% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -12337.746% |
| Apollomics, Inc. | -54.83 Million USD | -2154.111% |
| 180 Life Sciences Corp. | -13.47 Million USD | -9070.981% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -3839.252% |
| Bicycle Therapeutics plc | -189.94 Million USD | -550.721% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -1372.959% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -619.528% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -4789.316% |
| Chimerix, Inc. | -93.06 Million USD | -1228.124% |
| CRISPR Therapeutics AG | -222.53 Million USD | -455.419% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 7788.12% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -1577.96% |
| Fortress Biotech, Inc. | -142.34 Million USD | -768.345% |
| Fortress Biotech, Inc. | -142.34 Million USD | -768.345% |
| Gritstone bio, Inc. | -154.63 Million USD | -699.319% |
| Allakos Inc. | -196.05 Million USD | -530.442% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -2155.674% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -917.341% |
| Cytokinetics, Incorporated | -496.2 Million USD | -149.094% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -4642.974% |
| Innoviva, Inc. | 176.7 Million USD | 799.466% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -15968.384% |
| NLS Pharmaceutics AG | -11.8 Million USD | -10368.471% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -872.768% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -9585202.452% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -1105.19% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -1290.88% |
| ImmuCell Corporation | -5.74 Million USD | -21403.17% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -819.459% |
| Incyte Corporation | 620.52 Million USD | 299.189% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -814.035% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -18816.664% |
| Mustang Bio, Inc. | -50.72 Million USD | -2336.658% |
| MiMedx Group, Inc. | 37.11 Million USD | 3430.151% |
| MEI Pharma, Inc. | 14.54 Million USD | 8599.649% |
| MacroGenics, Inc. | -168.24 Million USD | -634.659% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -13895.993% |
| Mereo BioPharma Group plc | -28.41 Million USD | -4249.729% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -8376.695% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -840.046% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -3805.52% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -5246.201% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -7680.555% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -10158.27% |
| NextCure, Inc. | -67.63 Million USD | -1727.43% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -2299.757% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -11601.401% |
| Onconetix, Inc. | -36.03 Million USD | -3330.09% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -2863.08% |
| Opthea Limited | -191.84 Million USD | -544.288% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -1985.001% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -44816.337% |
| PDS Biotechnology Corporation | -43.04 Million USD | -2771.442% |
| Precigen, Inc. | -88.92 Million USD | -1289.988% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -4053.848% |
| Prime Medicine, Inc. | -191.29 Million USD | -546.143% |
| PureTech Health plc | -146.19 Million USD | -745.436% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -376.016% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 130.541% |
| Replimune Group, Inc. | -234.77 Million USD | -426.474% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -14178.237% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -5932.009% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -6265.157% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -153.706% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -4985.115% |
| Sesen Bio, Inc. | -25.9 Million USD | -4670.616% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -351.094% |
| Solid Biosciences Inc. | -104.31 Million USD | -1084.891% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -437.507% |
| SciSparc Ltd. | -5.77 Million USD | -21310.341% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -1284.461% |
| TG Therapeutics, Inc. | 20.63 Million USD | 6090.496% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -944.111% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -16885.282% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -228.079% |
| UroGen Pharma Ltd. | -65.53 Million USD | -1786.015% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -1779.62% |
| XOMA Corporation | -41.84 Million USD | -2853.592% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -396.417% |
| AbCellera Biologics Inc. | -237.2 Million USD | -421.072% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -2077.662% |
| Cassava Sciences, Inc. | -105.95 Million USD | -1066.529% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -2641.999% |
| Precision BioSciences, Inc. | -43.73 Million USD | -2726.091% |
| Dyadic International, Inc. | -8.22 Million USD | -14918.933% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -14757.783% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -103592.869% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -4124.551% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -842.138% |
| IGM Biosciences, Inc. | -263.46 Million USD | -369.147% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -1049.55% |
| Acelyrin, Inc. | -422.06 Million USD | -192.851% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -2522.296% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 10450.184% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -6052.473% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -1480.486% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -858.243% |
| Senti Biosciences, Inc. | -92.72 Million USD | -1232.966% |
| Mesoblast Limited | -58.79 Million USD | -2002.288% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -646.704% |
| ChromaDex Corporation | -5.59 Million USD | -21975.71% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -25696.259% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -2572.127% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -15269.727% |
| Seer, Inc. | -103.46 Million USD | -1094.648% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -2708.496% |
| Novavax, Inc. | -566.51 Million USD | -118.181% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -7777.857% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -548.791% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -2270.214% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -403.472% |
| Celcuity Inc. | -66.23 Million USD | -1766.243% |
| ContextLogic Inc. | -328 Million USD | -276.835% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -638.751% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -1165.194% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 313.63% |
| Amarin Corporation plc | -67.58 Million USD | -1728.755% |
| AnaptysBio, Inc. | -164.41 Million USD | -651.786% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -4180.141% |
| Aptorum Group Limited | -10.52 Million USD | -11645.512% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -1330.313% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -502.93% |
| Ardelyx, Inc. | -63.27 Million USD | -1853.377% |
| Celularity Inc. | -192.28 Million USD | -542.799% |
| Omeros Corporation | -164.53 Million USD | -651.242% |
| Humacyte, Inc. | -100.04 Million USD | -1135.438% |
| Immunocore Holdings plc | -59.64 Million USD | -1972.154% |
| IO Biotech, Inc. | -91.44 Million USD | -1251.682% |
| GT Biopharma, Inc. | -13.57 Million USD | -9004.442% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -1555.53% |
| Summit Therapeutics Inc. | -89.73 Million USD | -1277.395% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -3507.024% |
| Pulmatrix, Inc. | -14.74 Million USD | -8285.475% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -139.868% |
| Evogene Ltd. | -26.39 Million USD | -4583.487% |
| CorMedix Inc. | -48.95 Million USD | -2424.663% |
| BioLineRx Ltd. | -49.69 Million USD | -2387.26% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -3643.13% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -3920.882% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -253.753% |
| scPharmaceuticals Inc. | -55.39 Million USD | -2131.242% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -1016.912% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 1252.122% |
| NLS Pharmaceutics AG | -11.8 Million USD | -10368.471% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -4985.115% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -614.999% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -5658.031% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -4707.916% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -976.925% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -1388.229% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -2226.563% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -6440.581% |
| Daré Bioscience, Inc. | -30.83 Million USD | -3907.859% |
| bluebird bio, Inc. | -244.26 Million USD | -406.022% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 735.678% |
| DBV Technologies S.A. | -76.43 Million USD | -1517.149% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -424.631% |
| Galecto, Inc. | -39.9 Million USD | -2997.404% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -3234.824% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -2277.28% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -463.823% |
| GlycoMimetics, Inc. | -39.27 Million USD | -3047.065% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -412.656% |
| ADMA Biologics, Inc. | 21.63 Million USD | 5813.845% |
| Clene Inc. | -40.54 Million USD | -2948.888% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -253.088% |
| Aptose Biosciences Inc. | -52.35 Million USD | -2260.797% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -8471.1% |
| Soligenix, Inc. | -7.69 Million USD | -15956.49% |
| Century Therapeutics, Inc. | -146.54 Million USD | -743.434% |
| Kura Oncology, Inc. | -165.8 Million USD | -645.47% |
| Surrozen, Inc. | -45.78 Million USD | -2599.91% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -1222.54% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -49706.559% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -18962.6% |
| Autolus Therapeutics plc | -195.02 Million USD | -533.765% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -1360.032% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -5748.209% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -964.992% |
| GRI Bio, Inc. | -11.38 Million USD | -10754.65% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -27271.502% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -1593.664% |
| INmune Bio, Inc. | -29.74 Million USD | -4055.943% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -1017.406% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -3146.247% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -7635.097% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -14911.269% |
| Jaguar Health, Inc. | -34.29 Million USD | -3504.5% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -7737.376% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -1923.011% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -4875.121% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -347.823% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -508.28% |
| Verastem, Inc. | -92.08 Million USD | -1242.273% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -571.221% |
| Histogen Inc. | -10.64 Million USD | -11513.445% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -7888.768% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -1584.432% |
| Surrozen, Inc. | -45.78 Million USD | -2599.91% |
| Organovo Holdings, Inc. | -15.08 Million USD | -8093.153% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -24182.155% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -16093.429% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -621.624% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -2451.231% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -8020.605% |
| Kronos Bio, Inc. | -121.83 Million USD | -914.544% |
| Turnstone Biologics Corp. | -59.03 Million USD | -1993.812% |
| Synaptogenix, Inc. | -8.31 Million USD | -14766.98% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -8374.009% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -38989.785% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -1248.027% |
| Exelixis, Inc. | 170.88 Million USD | 823.305% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -697.108% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | -139.019% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -1694.948% |
| ESSA Pharma Inc. | -32.13 Million USD | -3746.44% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -7118.45% |
| Avid Bioservices, Inc. | -18.67 Million USD | -6517.513% |
| Insmed Incorporated | -709.62 Million USD | -74.179% |
| MediWound Ltd. | -15.29 Million USD | -7983.839% |
| OmniAb, Inc. | -69.41 Million USD | -1680.52% |
| Alector, Inc. | -151.74 Million USD | -714.564% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -1044.642% |
| Zai Lab Limited | -366.57 Million USD | -237.182% |
| AlloVir, Inc. | -181.33 Million USD | -581.637% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -290.186% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -1015.742% |
| Aura Biosciences, Inc. | -84.99 Million USD | -1354.294% |
| Immunic, Inc. | -99.22 Million USD | -1145.698% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -763.395% |
| Veracyte, Inc. | -85.79 Million USD | -1340.666% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -338.592% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -8598.234% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 1523.788% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -17844.665% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -6477.152% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -4756.084% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 3285.452% |
| Fortrea Holdings Inc. | 63.1 Million USD | 2058.826% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -780.073% |
| XBiotech Inc. | -37.51 Million USD | -3195.172% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -1694.948% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -627.322% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -3163.934% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -1741.506% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -1045.459% |
| Agenus Inc. | -159.54 Million USD | -674.696% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -4714.658% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -2219.333% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | -117.147% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -1474.707% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -1091.815% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -5454.359% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -789.024% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -21892.704% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -4754.939% |
| Lantern Pharma Inc. | -17.87 Million USD | -6813.798% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -2774.463% |
| Ainos, Inc. | -13.2 Million USD | -9259.245% |
| Pluri Inc. | -22.15 Million USD | -5478.207% |
| Prothena Corporation plc | -191.03 Million USD | -547.008% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -795.419% |
| Rallybio Corporation | -78.93 Million USD | -1465.929% |
| Kodiak Sciences Inc. | -277.32 Million USD | -345.7% |
| Cue Biopharma, Inc. | -52.14 Million USD | -2270.168% |
| MeiraGTx Holdings plc | -137.06 Million USD | -801.802% |
| Annexon, Inc. | -143.72 Million USD | -760.001% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -1811.981% |
| Moderna, Inc. | -4.23 Billion USD | 70.842% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -6559.944% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -4948.479% |
| Blueprint Medicines Corporation | -486.27 Million USD | -154.18% |
| Immix Biopharma, Inc. | -16.14 Million USD | -7557.582% |
| CalciMedica, Inc. | -21.87 Million USD | -5550.373% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -762.473% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -621.573% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -1717.782% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -278.103% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -3357.879% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -1729.757% |
| Nutriband Inc. | -4.87 Million USD | -25270.233% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -2734.061% |
| Vor Biopharma Inc. | -126.03 Million USD | -880.687% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 129.138% |
| Alkermes plc | 414.12 Million USD | 398.467% |
| ProKidney Corp. | -151.52 Million USD | -715.736% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -1815.269% |
| Arcellx, Inc. | -89.88 Million USD | -1275.188% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | -103.503% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -982.584% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -3146.53% |
| Atai Life Sciences N.V. | -125.47 Million USD | -885.103% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -1414.0% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -1418.283% |
| MediciNova, Inc. | -9.9 Million USD | -12384.706% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -878.072% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -16966.289% |
| GeoVax Labs, Inc. | -26.74 Million USD | -4521.852% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -433.169% |
| Biomea Fusion, Inc. | -126.13 Million USD | -879.918% |
| RenovoRx, Inc. | -11.39 Million USD | -10746.078% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -546.829% |
| Geron Corporation | -193.94 Million USD | -537.307% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -4380.44% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -995.111% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -410.41% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -4805.616% |
| Royalty Pharma plc | 1.49 Billion USD | 182.835% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -494.257% |
| Imunon, Inc. | -21.03 Million USD | -5777.288% |
| BioAtla, Inc. | -129.68 Million USD | -853.079% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -277.137% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -2859.957% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -623.0% |
| Structure Therapeutics Inc. | -102.77 Million USD | -1102.646% |
| 89bio, Inc. | -151.2 Million USD | -717.451% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -1074.51% |
| aTyr Pharma, Inc. | -54.91 Million USD | -2150.622% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -1313.773% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -385.761% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -14949.992% |
| Akari Therapeutics, Plc | -16.8 Million USD | -7254.629% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -13977224.514% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 466.148% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -619.662% |
| Liquidia Corporation | -73.38 Million USD | -1584.317% |
| Entera Bio Ltd. | -8.89 Million USD | -13801.912% |
| GH Research PLC | -41.22 Million USD | -2898.445% |
| Vericel Corporation | -6.46 Million USD | -19021.581% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -1482.55% |
| Xencor, Inc. | -138.63 Million USD | -791.538% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -23879.03% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -7635.097% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -5651.301% |
| Vaxcyte, Inc. | -468.04 Million USD | -164.083% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -477.433% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -8759.081% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -18816.664% |
| Portage Biotech Inc. | -18.25 Million USD | -6671.594% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -16966.289% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -1077.598% |
| OncoCyte Corporation | -25.13 Million USD | -4817.326% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -10833.522% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -10688.273% |
| Purple Biotech Ltd. | 22.27 Million USD | 5649.903% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -4139.184% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -4117.775% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -570.449% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -16353.927% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -4071.371% |
| United Therapeutics Corporation | 1.18 Billion USD | 204.314% |
| HilleVax, Inc. | -133.34 Million USD | -826.933% |
| Silo Pharma, Inc. | -3.85 Million USD | -31957.827% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -31254.743% |
| Pharming Group N.V. | -4.87 Million USD | -25230.625% |
| Tharimmune, Inc. | -9.45 Million USD | -12972.345% |
| Genprex, Inc. | -31.07 Million USD | -3877.462% |
| Apogee Therapeutics, Inc. | -93 Million USD | -1229.01% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -556.779% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -1403.746% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -161471.111% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -22592.076% |
| OKYO Pharma Limited | -15.74 Thousand USD | -7847774.218% |
| Savara Inc. | -60 Million USD | -1959.791% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -6947.26% |
| Curis, Inc. | -48.33 Million USD | -2457.351% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -23590.87% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -4435.85% |
| BeiGene, Ltd. | -1.2 Billion USD | -2.342% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -1219.8% |
| Erasca, Inc. | -141.52 Million USD | -773.357% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -27203.426% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -27203.426% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -2800.84% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -19334.261% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -1738.302% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -699.795% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -493.869% |
| Adicet Bio, Inc. | -152.03 Million USD | -712.967% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -1581.796% |
| Aditxt, Inc. | -26.06 Million USD | -4642.533% |
| Adagene Inc. | -23.71 Million USD | -5110.902% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -16808.378% |
| Quantum-Si incorporated | -111.17 Million USD | -1011.818% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -8378.795% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 1113.014% |
| Compugen Ltd. | -12.99 Million USD | -9413.693% |
| Generation Bio Co. | -138.56 Million USD | -792.027% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -1388.641% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -1329.585% |
| Invivyd, Inc. | -207.78 Million USD | -494.861% |
| Relay Therapeutics, Inc. | -373 Million USD | -231.372% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -13079.277% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 5854.011% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -11915.349% |
| 2seventy bio, Inc. | -216.7 Million USD | -470.375% |
| Instil Bio, Inc. | -159.16 Million USD | -676.545% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -5033.426% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -33587.51% |
| GeoVax Labs, Inc. | -26.74 Million USD | -4521.852% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -3264.964% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -1091.895% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -625.883% |
| Vir Biotechnology, Inc. | -684.3 Million USD | -80.624% |
| Evaxion Biotech A/S | -22.19 Million USD | -5468.406% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -1400.351% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -453.961% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -1446.087% |
| Cingulate Inc. | -22.75 Million USD | -5330.857% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 16597.851% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -2667.186% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -1891.202% |
| Clearmind Medicine Inc. | -8.74 Million USD | -14039.91% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -1522.157% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -42042.016% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -1125.881% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -224.844% |
| ImmunityBio, Inc. | -362.25 Million USD | -241.206% |
| Korro Bio, Inc. | -84.53 Million USD | -1362.156% |
| Kineta, Inc. | -15.72 Million USD | -7761.216% |
| BioVie Inc. | -32.17 Million USD | -3741.004% |
| Codexis, Inc. | -68.06 Million USD | -1715.832% |
| Celularity Inc. | -192.28 Million USD | -542.799% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -7494.12% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -455.245% |
| Virax Biolabs Group Limited | -6.49 Million USD | -18926.001% |
| Cibus, Inc. | -318.88 Million USD | -287.609% |
| IN8bio, Inc. | -30.33 Million USD | -3974.295% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -898.472% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -5172.219% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -249.424% |
| Eyenovia, Inc. | -25.4 Million USD | -4764.982% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 3886.823% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -22122.564% |
| Elevation Oncology, Inc. | -45.44 Million USD | -2619.813% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -1461.951% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -2621.789% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -800.843% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -3873.188% |
| Moolec Science SA | -6.65 Million USD | -18476.123% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -1921.687% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -2757.649% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -652.926% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -2354.22% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -13150.823% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -5545.298% |
| Humacyte, Inc. | -100.04 Million USD | -1135.438% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -1442.479% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -8400.818% |
| Genelux Corporation | -24.16 Million USD | -5014.914% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -3543.602% |
| Notable Labs, Ltd. | -14.65 Million USD | -8332.96% |
| Immunovant, Inc. | -282.7 Million USD | -337.205% |
| Quantum-Si incorporated | -111.17 Million USD | -1011.818% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -5711.91% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -1111.641% |
| Acasti Pharma Inc. | -11.31 Million USD | -10826.618% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -5292.493% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -2886.707% |
| PepGen Inc. | -84.76 Million USD | -1358.154% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -5298.17% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -3667.418% |
| Immuneering Corporation | -58.41 Million USD | -2016.004% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -24182.155% |
| Belite Bio, Inc | -31.66 Million USD | -3803.054% |
| XOMA Corporation | -41.84 Million USD | -2853.592% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -1730.597% |
| Bionomics Limited | -17.89 Billion USD | 93.092% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 3564.179% |
| uniQure N.V. | -282.87 Million USD | -336.955% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -16808.378% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -854.425% |
| Forte Biosciences, Inc. | -32.48 Million USD | -3704.774% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -14776.104% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -4104.861% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -22122.564% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -8598.234% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -13805.04% |
| Altimmune, Inc. | -95.92 Million USD | -1188.473% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -1590.629% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 3564.179% |
| Peak Bio, Inc. | -1356.23 USD | -91136285.421% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -2391.773% |
| Benitec Biopharma Inc. | -22.49 Million USD | -5395.86% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -410.113% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -4055.244% |
| Zura Bio Limited | -62.63 Million USD | -1873.273% |
| PolyPid Ltd. | -22.86 Million USD | -5305.252% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -4055.244% |
| argenx SE | -425.04 Million USD | -190.794% |
| Immunome, Inc. | -109.53 Million USD | -1028.475% |
| Verona Pharma plc | -67.83 Million USD | -1722.206% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -4642.974% |
| Shattuck Labs, Inc. | -91.95 Million USD | -1244.127% |
| CervoMed Inc. | -7.81 Million USD | -15720.243% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -9178.725% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -2465.739% |
| Moolec Science SA | -6.65 Million USD | -18476.123% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -7414.506% |
| Design Therapeutics, Inc. | -78.19 Million USD | -1480.789% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -1320.042% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -2951.974% |
| Achilles Therapeutics plc | -75.25 Million USD | -1542.441% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -42042.016% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -2129.11% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -2331.385% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -1769.951% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -2183.718% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -2621.969% |
| Beam Therapeutics Inc. | -176.48 Million USD | -600.354% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -1032.363% |
| AEON Biopharma, Inc. | -48.42 Million USD | -2452.229% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -1618.292% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -1379.748% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -9719.887% |
| NeurAxis, Inc. | -6.66 Million USD | -18446.326% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -168.374% |
| Lumos Pharma, Inc. | -36.61 Million USD | -3275.81% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 24070.994% |
| Palisade Bio, Inc. | -13.07 Million USD | -9356.917% |
| Nutriband Inc. | -4.87 Million USD | -25270.233% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -1606.289% |
| Neurogene Inc. | -55.58 Million USD | -2123.736% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -14439.689% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -1178.067% |
| Athira Pharma, Inc. | -125.46 Million USD | -885.143% |
| HCW Biologics Inc. | -25.71 Million USD | -4706.203% |
| XOMA Corporation | -41.84 Million USD | -2853.592% |
| Nektar Therapeutics | -137.42 Million USD | -799.413% |
| Arvinas, Inc. | -401.5 Million USD | -207.85% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -13977224.514% |
| Merus N.V. | -156.54 Million USD | -689.551% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -1132.801% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -3470.246% |
| Rezolute, Inc. | -70.42 Million USD | -1655.135% |
| Clene Inc. | -40.54 Million USD | -2948.888% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -7446.607% |
| BeyondSpring Inc. | -23.11 Million USD | -5247.491% |
| Synlogic, Inc. | -55.16 Million USD | -2140.748% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -6793.965% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -11319.244% |
| Peak Bio, Inc. | -1356.23 USD | -91136285.421% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -2951.673% |
| Krystal Biotech, Inc. | -109.72 Million USD | -1026.449% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -854.16% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -260.342% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -25943.642% |
| MannKind Corporation | 8.67 Million USD | 14343.132% |
| Ikena Oncology, Inc. | -75.41 Million USD | -1538.913% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -12712.47% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -1738.493% |
| Gossamer Bio, Inc. | -183.75 Million USD | -572.63% |
| CohBar, Inc. | -12.38 Million USD | -9877.312% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -2336.754% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -4380.44% |
| Legend Biotech Corporation | -439.48 Million USD | -181.243% |
| Mural Oncology plc | -194.63 Million USD | -535.035% |
| Disc Medicine, Inc. | -91.12 Million USD | -1256.399% |
| Champions Oncology, Inc. | -7.35 Million USD | -16702.868% |
| REGENXBIO Inc. | -268.12 Million USD | -360.981% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -11431.978% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -2116.836% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -3072.481% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -980.842% |
| Vaxart, Inc. | -83.34 Million USD | -1382.98% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -14407.252% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -2788.294% |
| Cellectis S.A. | -106.62 Million USD | -1059.21% |
| Longeveron Inc. | -21.02 Million USD | -5777.688% |
| Repare Therapeutics Inc. | -116.22 Million USD | -963.48% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -361.504% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -1533.973% |
| Revolution Medicines, Inc. | -487.18 Million USD | -153.706% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -18481.164% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -2712.074% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -1557.084% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -1674.997% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -11125.311% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 128.695% |
| Denali Therapeutics Inc. | -196.69 Million USD | -528.381% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -14178.237% |
| Veru Inc. | -93.78 Million USD | -1217.967% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -5198.208% |
| Cingulate Inc. | -22.75 Million USD | -5330.857% |
| Passage Bio, Inc. | -108.38 Million USD | -1040.355% |
| Context Therapeutics Inc. | -25.07 Million USD | -4829.757% |
| Exicure, Inc. | -14.99 Million USD | -8142.325% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -499.823% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -2944.532% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -12620.253% |
| Nuvalent, Inc. | -149.49 Million USD | -726.813% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -14943.116% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -1292.996% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -5849.836% |
| OmniAb, Inc. | -69.41 Million USD | -1680.52% |
| Anew Medical, Inc. | -1.3 Million USD | -94916.989% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -9578.326% |
| Lipocine Inc. | -17.93 Million USD | -6793.213% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -1704.065% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -1523.095% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -3146.247% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -3027.025% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -5421.886% |
| Sage Therapeutics, Inc. | -579.84 Million USD | -113.162% |
| Ocugen, Inc. | -65.53 Million USD | -1786.159% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -1216.791% |
| Q32 Bio Inc. | -92.1 Million USD | -1242.011% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -5665.283% |
| Alumis Inc. Common Stock | -158.17 Million USD | -681.43% |
| Equillium, Inc. | -14.52 Million USD | -8411.355% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -1880.609% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -15539.18% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -6451.879% |
| Dominari Holdings Inc. | -21.79 Million USD | -5570.852% |
| Edesa Biotech, Inc. | -9.22 Million USD | -13301.837% |
| vTv Therapeutics Inc. | -25.5 Million USD | -4746.753% |
| Bio-Techne Corporation | 206.68 Million USD | 698.018% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -215.724% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 743.659% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -834.417% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -3119.554% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -718.008% |
| Nkarta, Inc. | -131.65 Million USD | -838.867% |
| BioCardia, Inc. | -11.64 Million USD | -10515.072% |
| Iterum Therapeutics plc | -47.46 Million USD | -2503.899% |